Tokyo, Japan

Junwen Qin

This inventor holds 1 USPTO granted patent. Top assignees: The University of Tokyo, Tk Health Research, Co, Ltd.. Active years: 2022.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Junwen Qin. Retrieved from https://idiyas.com/inventor/junwen-qin

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2022

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Junwen Qin - Innovator in Ophthalmic Composition

Introduction

Junwen Qin is a notable inventor based in Tokyo, Japan. He has made significant contributions to the field of ophthalmology through his innovative research and development of ophthalmic compositions.

Latest Patents

Junwen Qin holds 1 patent for his invention titled "Ophthalmic composition containing clathrated antioxidant substance, and use thereof." This invention provides an ophthalmic composition that includes a clathrated antioxidant substance. The composition is designed for treating or preventing various ophthalmic diseases and disorders, such as dry eye, conjunctivitis, corneal ulcers, age-related macular degeneration, cataracts, and pseudoexfoliation syndrome. The invention aims to ameliorate symptoms by increasing the quantity of tears, goblet cells, and mucin.

Career Highlights

Throughout his career, Junwen Qin has worked with reputable organizations, including Tk Health Research Co., Ltd. and The University of Tokyo. His work has focused on advancing the understanding and treatment of ophthalmic conditions.

Collaborations

Junwen Qin has collaborated with esteemed colleagues, including Yuji Takahashi and Shigeru Kakuta, to further his research and innovations in the field.

Conclusion

Junwen Qin's contributions to ophthalmic compositions highlight his dedication to improving eye health and treatment options. His innovative work continues to impact the field positively.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…